Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo
Research use only24h dispatchLot-tracked COA

Research supplies & diluents

Acetic Acid Sterile Solution

Research-grade sterile acetic acid solution is a sealed aqueous diluent supplied for in vitro laboratory preparation when a protocol needs an acidic aqueous medium rather than water alone. VaultLabs catalogs 3 ml and 10 ml vials. It is a research supply, not a peptide, not glacial reagent-bottle stock, and not for human or animal use.

Research use only. For in vitro research use only. Not for human or animal consumption. Not for human consumption, medical use, or personal application.

Reviewed by VaultLabs Research Editorial Desk · Last updated 2026-09-18

Key facts

  • The substance is acetic acid, CAS 64-19-7, formula C2H4O2, molecular weight 60.05 g/mol, supplied as a sterile dilute aqueous solution.
  • It is a diluent, not an active peptide. Certificates describe the liquid supply, not a peptide purity figure.
  • Catalog presentations are 3 ml (VL-AA-3) and 10 ml (VL-AA-10) sealed vials. Strength here means vial volume.
  • Peptide laboratories use dilute acetic acid when a sequence is poorly soluble in water or when an acetate counter-ion context is required by the method.
  • It is not bacteriostatic water and not sterile water. Those are separate SKUs with different compositions.
  • Not for injection, not a USP drug product, and not for human or veterinary use.
Material type
Sterile aqueous acetic acid diluent
Chemical name
Acetic acid
CAS number
64-19-7
Molecular formula
C2H4O2
Molecular weight
60.05 g/mol
Appearance
Clear sterile liquid in a sealed vial
Catalog presentations
3 ml and 10 ml vials
Supply status
Research use only — not for human or animal use

What this diluent is

Acetic acid is a two-carbon carboxylic acid. In a peptide laboratory it appears as a mobile-phase modifier, as the source of acetate counter-ions after salt exchange, and as a solvent for sequences that do not dissolve cleanly in water. VaultLabs supplies a sterile sealed solution for those in vitro preparation workflows, not a bulk bottle of glacial reagent and not a finished pharmaceutical article.

The CAS number 64-19-7, formula C2H4O2 and mass 60.05 g/mol identify the acid. They do not by themselves identify the vial concentration. Read the batch label and the published certificate for the lot in hand. This monograph will not invent a percentage that the catalog does not publish.

Naming collisions are mostly with vinegar-grade acetic acid and with glacial reagent. Neither is this SKU. The VaultLabs article is a sealed sterile research diluent in 3 ml and 10 ml presentations, grouped at acetic acid.

Why peptide laboratories reach for acetic acid

Many synthetic peptides leave the factory as trifluoroacetate salts because TFA is the cleavage and HPLC ion-pairing acid. Roux, Zékri, Rousseau and colleagues evaluated, in the Journal of Peptide Science (2008), how to exchange that tightly bound trifluoroacetate for another counter-ion — including acetate from acetic acid — using HPLC, ion-exchange resin, or a deprotonation/reprotonation cycle. The paper is about salt form, not about drinking the acid.

Cornish, Callon, Lin and colleagues reported in the American Journal of Physiology (1999) that residual trifluoroacetate in purified proteins inhibited proliferation of cultured osteoblasts and chondrocytes. That in vitro result is one documented reason cell-based methods specify acetate or another non-TFA counter-ion. It is not a claim that VaultLabs acetic acid "fixes" a peptide, and it is not a reason to use the diluent in a human.

Choose bacteriostatic water when the SOP wants a preserved multi-draw aqueous vial. Choose sterile water when the SOP wants unpreserved water. Choose this acetic acid line when the method needs an acidic aqueous medium. Those are three different liquids.

Choosing a vial volume and recording the lot

3 ml suits a laboratory that prepares one or two vials and prefers to retire the diluent quickly. 10 ml suits a preparation day that should carry one diluent lot number across several peptide records. Volume is an inventory decision, not a quality ranking.

Record the diluent lot next to the peptide lot. If a preparation is questioned later, "which water" is an incomplete answer when the medium was acetic acid. Where a certificate has been published, match the vial number through batch verification or COA search before the closure is pierced.

Diluent certificates speak to the liquid and its microbial or identity tests. They do not report a peptide HPLC purity. Read them for what they claim.

Handling, storage and permitted use

Keep sealed vials as the batch label specifies, protected from contamination. Do not use a vial that arrived with a compromised seal, a discoloured solution or visible particulate. Opened-vial hold time is defined by the receiving laboratory's quality system, not by a VaultLabs protocol.

Acetic acid is corrosive and has a characteristic vapour. Institutional chemical-hygiene rules apply even when the presentation is a small sterile vial. Review the safety documentation that accompanies the lot.

VaultLabs acetic acid solution is supplied for in vitro laboratory research only. It is not for human or animal use, not for injection into any subject, and not a substitute for a pharmacy-supplied or reagent-bottle article. This page is a reference article, not a preparation instruction.

Research interest areas

Acidic aqueous reconstitution

Acetate-medium analytical prep

Diluent qualification

Storage information

Per batch label (sealed)

Keep sealed vials as the batch label specifies, protected from contamination. Do not use a vial that arrived with a compromised seal.

Stability notes

Opened-vial hold time is defined by the receiving laboratory’s SOP, not by a VaultLabs protocol. Document the open date if your quality system requires it.

Selected literature

Named papers behind the statements on this page. Each entry resolves on PubMed and through its DOI, so you can read the source rather than take our summary of it. Inclusion describes the research record and is not a claim about this material’s suitability for any use.

  1. Elimination and exchange of trifluoroacetate counter-ion from cationic peptides: a critical evaluation of different approaches

    Roux S, et al. · Journal of Peptide Science · 2008

    Compares HPLC, resin and deprotonation methods for exchanging peptide trifluoroacetate for acetate using acetic acid as the weaker-acid counter-ion source.

    PubMed 18035848doi:10.1002/psc.951

  2. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes

    Cornish J, et al. · American Journal of Physiology · 1999

    In vitro evidence that residual TFA is not biologically inert in cultured bone and cartilage cells, a documented reason methods specify acetate rather than trifluoroacetate.

    PubMed 10567002doi:10.1152/ajpendo.1999.277.5.e779

Databases and verification

Registry and database entries for independent identity checks. These are standing searches rather than fixed records, so they stay current as new work is indexed.

FAQ